The Consolidated Appropriations Act of 2023 (Omnibus) amended the Federal Food, Drug, and Cosmetic Act to require medical device manufacturers to address cybersecurity. As of March 29, 2023, they must provide cybersecurity details in premarket submissions. The Omnibus mandates plans for postmarket cybersecurity vulnerabilities, device cybersecurity demonstrations, and software bill of materials (SBOM) disclosures. Starting October 1, 2023, the FDA will reject submissions not meeting cybersecurity criteria, emphasizing proactive cybersecurity measures.
Hackers Abuse Fake Wallpaper App and YouTube Channel to Spread notnullOSX Malware
A new macOS malware called notnullOSX has surfaced in early 2026, specifically built to steal cryptocurrency from Mac users who hold digital assets worth more
